[HTML][HTML] Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: results from the cross-sectional ASTRA …

M Daskalopoulou, A Rodger, AN Phillips, L Sherr… - The lancet HIV, 2014 - thelancet.com
Background Recreational drug use in men who have sex with men (MSM) is of concern
because it might be linked to the transmission of HIV and other sexually transmitted …

[HTML][HTML] Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population

A Miners, A Phillips, N Kreif, A Rodger, A Speakman… - The lancet HIV, 2014 - thelancet.com
Background Combination antiretroviral therapy has substantially increased life-expectancy
in people living with HIV, but the effects of chronic infection on health-related quality of life …

Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics

J Sewell, A Miltz, FC Lampe, V Cambiano… - International Journal of …, 2017 - Elsevier
Background Recreational drug use and associated harms continue to be of significant
concern in men who have sex with men (MSM) particularly in the context of HIV and STI …

[HTML][HTML] Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses

LS Burch, CJ Smith, J Anderson, L Sherr… - The Lancet Public …, 2016 - thelancet.com
Background Few studies have assessed the effect of socioeconomic status on HIV treatment
outcomes in settings with universal access to health care. Here we aimed to investigate the …

[HTML][HTML] Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: findings from the AURAH2 study

J Sewell, V Cambiano, A Speakman, FC Lampe… - International Journal of …, 2019 - Elsevier
Background Recent evidence has suggested that chemsex (the use of mephedrone, crystal
methamphetamine and γ-hydroxybutyrate/γ-butryolactone (GHB/GBL) to enable, enhance …

Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and …

J Sewell, V Cambiano, A Miltz, A Speakman… - Sexually Transmitted …, 2018 - sti.bmj.com
Objectives The objective of this study was to compare the prevalence of polydrug use, use of
drugs associated with chemsex, specific drug use, and HIV-related behaviours, between two …

[HTML][HTML] Non-disclosure of HIV status and associations with psychological factors, ART non-adherence, and viral load non-suppression among people living with HIV …

M Daskalopoulou, FC Lampe, L Sherr, AN Phillips… - AIDS and Behavior, 2017 - Springer
Disclosure of HIV status to family, friends, and a stable partner may be linked to improved
health outcomes for people living with HIV. This study assessed whether non-disclosure is …

[HTML][HTML] Minimal cognitive impairment in UK HIV-positive men who have sex with men: effect of case definitions and comparison with the general population and HIV …

J McDonnell, L Haddow… - JAIDS Journal of …, 2014 - journals.lww.com
Background: To determine the prevalence of neurocognitive impairment (NCI) in UK HIV-
positive and HIV-negative men who have sex with men (MSM). Methods: HIV-positive and …

Condomless sex in HIV-diagnosed men who have sex with men in the UK: prevalence, correlates, and implications for HIV transmission

M Daskalopoulou, AJ Rodger, AN Phillips… - Sexually Transmitted …, 2017 - sti.bmj.com
Objective HIV transmission is ongoing among men who have sex with men (MSM) in the UK.
Sex without a condom (condomless sex, CLS) is the main risk factor. We investigated the …

[HTML][HTML] Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study

N Hanum, V Cambiano, J Sewell, AN Phillips… - The Lancet Public …, 2020 - thelancet.com
Summary Background Since October, 2017 (and until October, 2020), pre-exposure
prophylaxis (PrEP) has only been available in England, UK, through the PrEP Impact Trial …